Q2'23 results due on 20 July at 7:00 CET. Orders to slow from a high level, org. sales growth at 17%. Op. EBITA flat for '23e, up 3% for '24e-'25e, keep HOLD.

13 Jul 2023
Margin to strengthen further
AbbVie (ABBV:NYSE), 0 | Abbott Laboratories (ABT:NYS), 0 | Abbott Laboratories (ABT:NYSE), 0 | AbbVie, Inc. (ABBV:NYS), 0 | ABB LTD-REG (ABB:VTX), 0 | ABBA MEDIX GROUP (ABA:TSE), 0 | ABB India Limited (500002:BOM), 0 | Abbott India Limited (500488:BOM), 0 | Abbisko Cayman Limited (2256:HKG), 0 | Abbey Mortgage Bank Plc (ABBEYBDS:NSA), 0 | ABBH AS (BUDS:NWTC), 0 | Abbott Laboratories Pakistan Limited (ABOT:KAR), 0 | Abby, Inc. (ABBY:OTC), 0

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Margin to strengthen further
AbbVie (ABBV:NYSE), 0 | Abbott Laboratories (ABT:NYS), 0 | Abbott Laboratories (ABT:NYSE), 0 | AbbVie, Inc. (ABBV:NYS), 0 | ABB LTD-REG (ABB:VTX), 0 | ABBA MEDIX GROUP (ABA:TSE), 0 | ABB India Limited (500002:BOM), 0 | Abbott India Limited (500488:BOM), 0 | Abbisko Cayman Limited (2256:HKG), 0 | Abbey Mortgage Bank Plc (ABBEYBDS:NSA), 0 | ABBH AS (BUDS:NWTC), 0 | Abbott Laboratories Pakistan Limited (ABOT:KAR), 0 | Abby, Inc. (ABBY:OTC), 0
- Published:
13 Jul 2023 -
Author:
ABGSC Capital Goods Research | Olof Cederholm | Anders Idborg -
Pages:
12 -
Q2'23 results due on 20 July at 7:00 CET. Orders to slow from a high level, org. sales growth at 17%. Op. EBITA flat for '23e, up 3% for '24e-'25e, keep HOLD.